Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
2241337-84-6	Bemnifosbuvir hemisulfate CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=NC3=C(N=C(N=C32)N)NC)(C)F)O)OC4=CC=CC=C4.CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=NC3=C(N=C(N=C32)N)NC)(C)F)O)OC4=CC=CC=C4.OS(=O)(=O)O	C₄₈H₆₈F₂N₁₄O₁₈P₂S	1261.1	98%	Click to inquire
1599440-15-9	MC-Gly-Gly-Phe C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CNC(=O)CNC(=O)CCCCCN2C(=O)C=CC2=O	C₂₃H₂₈N₄O₇	472.5	98%	Click to inquire
2088135-12-8	2-Chloro-N-(6-methoxy-4-quinolinyl)-5-nitrobenzamide COC1=CC2=C(C=CN=C2C=C1)NC(=O)C3=C(C=CC(=C3)[N+](=O)[O-])Cl	C₁₇H₁₂ClN₃O₄	357.7	98%	Click to inquire
851881-59-9	(4-fluorophenyl)-[(3R)-3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methanone C1CC(CN(C1)C(=O)C2=CC=C(C=C2)F)C3=NC(=NO3)C4=CC=C(C=C4)F	C₂₀H₁₇F₂N₃O₂	369.4	98%	Click to inquire
1976050-09-5	Valiglurax C1=CC2=C(NN=C2N=C1)NC3=CC4=C(C=C3)C(=NC=C4)C(F)(F)F	C₁₆H₁₀F₃N₅	329.28	98%	Click to inquire
897776-15-7	methyl (3-phenyl-1H-indazol-1-yl)acetate COC(=O)CN1C2=CC=CC=C2C(=N1)C3=CC=CC=C3	C₁₆H₁₄N₂O₂	266.29	98%	Click to inquire
1478712-37-6	4-(4-(((6-Methoxy-2-(2-methoxyimidazo[2,1-b][1,3,4]thiadiazol-6-yl)benzofuran-4-yl)oxy)methyl)-5-methylthiazol-2-yl)morpholine CC1=C(N=C(S1)N2CCOCC2)COC3=CC(=CC4=C3C=C(O4)C5=CN6C(=N5)SC(=N6)OC)OC	C₂₃H₂₃N₅O₅S₂	513.6	98%	Click to inquire
946293-78-3	Aumitin CC1=CC(=NC(=N1)NC2=CC=C(C=C2)NC(=O)C3=CC=CC=C3Cl)NC4=CC=CC=C4	C₂₄H₂₀ClN₅O	429.9	98%	Click to inquire
2448173-47-3	Menin-MLL inhibitor 20 CC(C)(C)OC(=O)NC1CCCN(C1)CC2=CC(=NC=C2)C(=O)NC3=CC=C(C=C3)C4=CC5=C(N4)N=CN=C5N6CCOCC6	C₃₃H₄₀N₈O₄	612.7	98%	Click to inquire
2222768-84-3	Dynarrestin CCN(CC)C1=CC=C(C=C1)C2=C(SC(=N2)NC3=C(C=C(C=C3)F)F)C(=O)OCC	C₂₂H₂₃F₂N₃O₂S	431.5	98%	Click to inquire

Bemnifosbuvir hemisulfate

C₄₈H₆₈F₂N₁₄O₁₈P₂S 1261.1

C₂₃H₂₈N₄O₇ 472.5

2-Chloro-N-(6-methoxy-4-quinolinyl)-5-nitrobenzamide

C₁₇H₁₂ClN₃O₄ 357.7

(4-fluorophenyl)-[(3R)-3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]methanone

C₂₀H₁₇F₂N₃O₂ 369.4

C₁₆H₁₀F₃N₅ 329.28

methyl (3-phenyl-1H-indazol-1-yl)acetate

C₁₆H₁₄N₂O₂ 266.29

4-(4-(((6-Methoxy-2-(2-methoxyimidazo[2,1-b][1,3,4]thiadiazol-6-yl)benzofuran-4-yl)oxy)methyl)-5-methylthiazol-2-yl)morpholine

C₂₃H₂₃N₅O₅S₂ 513.6

C₂₄H₂₀ClN₅O 429.9

Menin-MLL inhibitor 20

Menin-MLL inhibitor 20

C₃₃H₄₀N₈O₄ 612.7

C₂₂H₂₃F₂N₃O₂S 431.5

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 15689) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号